568 related articles for article (PubMed ID: 28443518)
1. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
[TBL] [Abstract][Full Text] [Related]
2. Natural product based leads to fight against leishmaniasis.
Singh N; Mishra BB; Bajpai S; Singh RK; Tiwari VK
Bioorg Med Chem; 2014 Jan; 22(1):18-45. PubMed ID: 24355247
[TBL] [Abstract][Full Text] [Related]
3. Leishmaniasis: current status of available drugs and new potential drug targets.
Singh N; Kumar M; Singh RK
Asian Pac J Trop Med; 2012 Jun; 5(6):485-97. PubMed ID: 22575984
[TBL] [Abstract][Full Text] [Related]
4. Leishmania treatment and prevention: Natural and synthesized drugs.
Bekhit AA; El-Agroudy E; Helmy A; Ibrahim TM; Shavandi A; Bekhit AEA
Eur J Med Chem; 2018 Dec; 160():229-244. PubMed ID: 30342363
[TBL] [Abstract][Full Text] [Related]
5. Screening natural products database for identification of potential antileishmanial chemotherapeutic agents.
Venkatesan SK; Saudagar P; Shukla AK; Dubey VK
Interdiscip Sci; 2011 Sep; 3(3):217-31. PubMed ID: 21956744
[TBL] [Abstract][Full Text] [Related]
6. Marine Algae as Source of Novel Antileishmanial Drugs: A Review.
Tchokouaha Yamthe LR; Appiah-Opong R; Tsouh Fokou PV; Tsabang N; Fekam Boyom F; Nyarko AK; Wilson MD
Mar Drugs; 2017 Oct; 15(11):. PubMed ID: 29109372
[TBL] [Abstract][Full Text] [Related]
7. An update on small molecule strategies targeting leishmaniasis.
Kapil S; Singh PK; Silakari O
Eur J Med Chem; 2018 Sep; 157():339-367. PubMed ID: 30099256
[TBL] [Abstract][Full Text] [Related]
8. Studies in vitro on infectivity and sensitivity to antileishmanial drugs in New World Leishmania species transfected with the green fluorescent protein [pIR3(-)-eGFP].
Palacios G; Parodi A; Upegui YA; Montoya A; Pulido S; Vélez ID; Robledo SM
Parasitology; 2017 Nov; 144(13):1718-1725. PubMed ID: 28831945
[TBL] [Abstract][Full Text] [Related]
9. Manzamine alkaloids as antileishmanial agents: A review.
Ashok P; Lathiya H; Murugesan S
Eur J Med Chem; 2015 Jun; 97():928-36. PubMed ID: 25023608
[TBL] [Abstract][Full Text] [Related]
10. Challenges and new discoveries in the treatment of leishmaniasis.
Singh S; Sivakumar R
J Infect Chemother; 2004 Dec; 10(6):307-15. PubMed ID: 15614453
[TBL] [Abstract][Full Text] [Related]
11. Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review.
Passero LFD; Cruz LA; Santos-Gomes G; Rodrigues E; Laurenti MD; Lago JHG
Curr Top Med Chem; 2018; 18(15):1275-1286. PubMed ID: 30277153
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasites.
Varela-M RE; Villa-Pulgarin JA; Yepes E; Müller I; Modolell M; Muñoz DL; Robledo SM; Muskus CE; López-Abán J; Muro A; Vélez ID; Mollinedo F
PLoS Negl Trop Dis; 2012; 6(4):e1612. PubMed ID: 22506086
[TBL] [Abstract][Full Text] [Related]
13. Promising therapeutic targets for antileishmanial drugs.
Werbovetz KA
Expert Opin Ther Targets; 2002 Aug; 6(4):407-22. PubMed ID: 12223057
[TBL] [Abstract][Full Text] [Related]
14. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
[TBL] [Abstract][Full Text] [Related]
15. Plants as Antileishmanial Agents: Current Scenario.
Ullah N; Nadhman A; Siddiq S; Mehwish S; Islam A; Jafri L; Hamayun M
Phytother Res; 2016 Dec; 30(12):1905-1925. PubMed ID: 27704633
[TBL] [Abstract][Full Text] [Related]
16. The chemotherapeutic potential of chalcones against leishmaniases: a review.
Tajuddeen N; Isah MB; Suleiman MA; van Heerden FR; Ibrahim MA
Int J Antimicrob Agents; 2018 Mar; 51(3):311-318. PubMed ID: 28668673
[TBL] [Abstract][Full Text] [Related]
17. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
18. Development of new antileishmanial drugs--current knowledge and future prospects.
Le Pape P
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):708-18. PubMed ID: 18671165
[TBL] [Abstract][Full Text] [Related]
19. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review.
Da Silva BJM; Hage AAP; Silva EO; Rodrigues APD
J Integr Med; 2018 Jul; 16(4):211-222. PubMed ID: 29691188
[TBL] [Abstract][Full Text] [Related]
20. Alkaloids: future prospective to combat leishmaniasis.
Mishra BB; Kale RR; Singh RK; Tiwari VK
Fitoterapia; 2009 Mar; 80(2):81-90. PubMed ID: 19015012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
